[December 17, 2014] |
|
Research and Markets: Global & USA Transdermal Drug Delivery Market to 2017
Research and Markets (http://www.researchandmarkets.com/research/tnkj5x/global_and_usa)
has announced the addition of the "Global
& USA Transdermal Drug Delivery Market to 2017" report to
their offering.
This is a comprehensive account of the market size, segmentation, key
players, SWOT analysis, influential technologies, and business and
economic environments. The report is supported by 320 tables & figures
over 280 pages.
This report is presented as follows:
-
By Company (e.g., JANSSEN, MYLAN, ACTAVIS, GLAXOSMITHKLINE, BAYER,
NOVARTIS, NOVEN, LAVIPHARM, PROSTRACKEN, NITTO DENTO)
-
By Geography (Global, USA)
-
By Parent Market (Drug Delivery Systems, Advanced Drug Delivery
Systems)
-
By Sub-market (Generics, Women's Health, Analgesics, Neuropathic Pain)
A wealth of financial data & business strategy information is provided
including:
-
Up-to-date company financials, sales & revenue figures
-
Revenue and market forecasts
-
Business model strategies for drug delivery, pharmaceutical and
biotechnology companies
-
Coprehensive account of company products, financials & portfolios
SWOT, Economic & Regulatory Environment specifics include:
-
Key strengths, weaknesses and threats influencing leading player
position within the market
-
Technologies driving the market (e.g., chemical enhancers,
microneedles)
-
Top fastest growing market segments and emerging opportunities
-
Top pharmaceutical companies within the market
-
Comprehensive product portfolios, R&D activity and pipeline products
-
M&A activity and future strategies of top companies
-
High demand and unmet need enhances the market
-
Challenges of the transdermal drug delivery market
Who should read this report?
-
Pharmaceutical, biotechnology and diagnostic companies with an
interest in personalized medicine
-
Industry professionals and business strategists will discover key
information to propel their policies
-
Investors will gain inside information to dominant players in the
industry and future forecasts
-
Scientists will get a business perspective and industry insight into
how scientific breakthroughs influence the market environment C-Suite
professionals, Decision Makers, Business Development professionals
This report will tell you if the companies mentioned are:
-
Strong, competitive players
-
Pooling their resources for specific growth and therapeutic areas
-
Investing strategically in R&D
-
Have a history of strategic M&A activity
Companies Mentioned
-
3M (News - Alert)
-
AMAG Pharmaceuticals (Lumara Health, KV Pharm/Ther-Rx Corp)
-
Actavis
-
Actelion
-
Ascend Therapeutics
-
Bayer
-
Boehringer Ingelheim
-
Endo International
-
GlaxoSmithKline
-
Hercon Pharmaceutical
-
Janssen Pharmaceuticals
-
Kremers Urban Pharmaceuticals
-
Mylan Pharmaceuticals
-
Nitto Denko
-
Novartis
-
Noven Pharmaceuticals
-
ParPharm
-
ProStrakan
-
Shire
-
Teikoku USA
-
Teva Pharmaceutical Industries
-
UCB
-
Upsher-Smith
For more information visit http://www.researchandmarkets.com/research/tnkj5x/global_and_usa
[ Back To TMCnet.com's Homepage ]
|